
Antihyperglycemic therapy during colonoscopy preparation: A review and suggestions for practical recommendations
Author(s) -
Hochberg Irit,
Segol Ori,
Shental Rachel,
Shimoni Pnina,
Eldor Roy
Publication year - 2019
Publication title -
ueg journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.667
H-Index - 35
eISSN - 2050-6414
pISSN - 2050-6406
DOI - 10.1177/2050640619846365
Subject(s) - medicine , bowel preparation , colonoscopy , intensive care medicine , diabetes mellitus , diabetic ketoacidosis , hypoglycemia , primary care , family medicine , colorectal cancer , endocrinology , cancer
Patients with diabetes have distinct risks during precolonoscopy bowel preparation, caused by change of diet, change of antihyperglycemic medication regimens and diabetes‐related complications and comorbidities. These risks include hypoglycemia, water and electrolyte imbalance, acute renal failure, lactic acidosis, ketoacidosis and low quality of bowel preparation. Here we review the existing literature and present recommendations from a subcommittee of the Israeli National Diabetes Council for primary care physicians and gastroenterologists. The instructions include general suggestions on diet and glucose monitoring and specific recommendations on timing of modification or cessation of each of the antihyperglycemic medication types to ensure patient safety during bowel preparation.